Guizhou Bailing Group Pharmaceutical Co (SZSE:002424) Long-Term Debt : ¥150 Mil (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Guizhou Bailing Group Pharmaceutical Co Long-Term Debt?

Guizhou Bailing Group Pharmaceutical Co's Long-Term Debt for the quarter that ended in Mar. 2024 was ¥150 Mil.

Guizhou Bailing Group Pharmaceutical Co's quarterly Long-Term Debt declined from Sep. 2023 (¥200 Mil) to Dec. 2023 (¥200 Mil) and declined from Dec. 2023 (¥200 Mil) to Mar. 2024 (¥150 Mil).

Guizhou Bailing Group Pharmaceutical Co's annual Long-Term Debt stayed the same from Dec. 2021 (¥0 Mil) to Dec. 2022 (¥0 Mil) but then increased from Dec. 2022 (¥0 Mil) to Dec. 2023 (¥200 Mil).

Guizhou Bailing Group Pharmaceutical Co Long-Term Debt Historical Data

The historical data trend for Guizhou Bailing Group Pharmaceutical Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guizhou Bailing Group Pharmaceutical Co Long-Term Debt Chart

Guizhou Bailing Group Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

212.85

203.88

199.78

Guizhou Bailing Group Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															150.17	150.18	200.21	199.78	149.71

Guizhou Bailing Group Pharmaceutical Co (SZSE:002424) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Guizhou Bailing Group Pharmaceutical Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Guizhou Bailing Group Pharmaceutical Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Guizhou Bailing Group Pharmaceutical Co (SZSE:002424) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guizhou Bailing Group Pharmaceutical Co Ltd (SZSE:002424) » Definitions » Long-Term Debt

Traded in Other Exchanges

N/A

Address

Economic and Technological Development Zone, Air Boulevard West, Anshun City, CHN, 561000

Website

http://www.gzbl.com

Guizhou Bailing Group Pharmaceutical Co Ltd is a China-based company. It is engaged in the production and sale of medicinal tablets, capsules, and syrups.

Executives

Jiang Wei	Director
Jiang Yong	Directors, executives
Chen Pei	Directors, executives
Kuang Xun Hua	Director
Niu Min	Directors, Directors, and Executives
Chen Zhi	Securities Affairs Representative
Zheng Rong	Executives
Li Qiang	Supervisors
Xia Wen	Supervisors
Wang Xiao Dong	Supervisors
Teng Chun Jie	Supervisors
Li Hui Fang	Supervisors
Zhang Jin Fen	Director
Cai Shou Xian	Executives

Guizhou Bailing Group Pharmaceutical Co (SZSE:002424) Headlines

No Headlines